Associated Papers
Polymorphisms in MDM2 and TP53 Genes and Risk of Developing Therapy-Related Myeloid Neoplasms.
Cabezas M et al.
Scientific Reports, 2019
30655613 (PubMed )
Supplement: 41598_2018_36931_MOESM1_ESM.docx
The p53 R72P polymorphism does not affect the physiological response to ionizing radiation in a mouse model.
Domínguez ER et al.
Cell Cycle (georgetown, Tex.), 2017
The traditional Chinese medical compound Rocaglamide protects nonmalignant primary cells from DNA damage-induced toxicity by inhibition of p53 expression.
Becker MS et al.
Cell Death & Disease, 2014
Select a paper to view details